Technology | Computed Tomography (CT) | June 18, 2019

Canon Medical Receives FDA Clearance for AiCE Reconstruction Technology for CT

Advanced Intelligent Clear-IQ Engine (AiCE) delivers high spatial resolution three to five times faster than model-based iterative reconstruction

Canon Medical Receives FDA Clearance for AiCE Reconstruction Technology for CT

June 18, 2019 – Canon Medical Systems USA Inc. has received 510(k) clearance on its new deep convolutional neural network (DCNN) image reconstruction technology, dubbed Advanced Intelligence Clear-IQ Engine (AiCE). AiCE uses a deep learning algorithm to differentiate signal from noise so that it can suppress noise while enhancing signal.

The algorithm, for computed tomography (CT) image reconstruction, has the ability to learn from the high image quality of Model Based Iterative Reconstruction (MBIR) to reconstruct CT images with improved spatial resolution (compared to Canon’s AIDR 3D technology), 3-5 times faster than traditional MBIR. With AiCE’s deep learning approach, thousands of features learned during training help to differentiate signal from noise for improved resolution. AiCE applies a pre-trained DCNN to enhance spatial resolution while simultaneously reducing noise with reconstruction speeds fast enough for busy clinical environments.

For more information: www.us.medical.canon

Related Content

Videos | Computed Tomography (CT) | July 19, 2019
Quynh Truong, M.D., MPH, associate professor of radio
Advances in long-length digital radiography are creating opportunities for visualization during spinal surgery, as well as pre- and post-operatively. Image courtesy of Fujifilm Medical Systems

Advances in long-length digital radiography are creating opportunities for visualization during spinal surgery, as well as pre- and post-operatively. Image courtesy of Fujifilm Medical Systems

Feature | Digital Radiography (DR) | July 19, 2019 | By Greg Freiherr
Recent advances in...
Low Doses of Radiation Promote Cancer-capable Cells
News | Radiation Dose Management | July 18, 2019
Low doses of radiation equivalent to three computed tomography (CT) scans, which are considered safe, give cancer-...
Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System

Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire.

Technology | Artificial Intelligence | July 18, 2019
Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded...
Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
Johns Hopkins Named Qualified Provider-led Entity to Develop Criteria for Diagnostic Imaging
News | Clinical Decision Support | July 18, 2019
On June 30, 2019, the Centers for Medicare & Medicaid Services (CMS) announced the Johns Hopkins University School...
Image by rawpixel from Pixabay

Image by rawpixel from Pixabay 

Feature | Radiology Business | July 18, 2019 | By Stefanie Manack and Judy Zakutny
Approximately 30 percent of a hospital or health system’s profit comes from imaging according, to...
New Lung Ambition Alliance Aims to Double Five-year Lung Cancer Survival by 2025
News | Lung Cancer | July 17, 2019
The International Association for the Study of Lung Cancer (IASLC), Guardant Health, the Global Lung Cancer Coalition (...